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Purpose: To assess the feasibility, safety, and effectiveness of a VIrtual PulmonAry Rehabilita-
tion (VIPAR) program in a real-world setting.
Patients and methods: Twenty-one patients with stable chronic lung disease at a spoke site 
received (VIPAR) through live video conferencing with a hub where 24 patients were receiv-
ing 14 sessions of standard, outpatient, multi-disciplinary pulmonary rehabilitation (PR) in a 
hospital. We studied three such consecutive PR programs with 6–10 patients at each site. The 
hub had a senior physiotherapist, occupational therapist, exercise assistant, and guest lecturer, 
and the spoke usually had only an exercise instructor and nurse present. Uptake, adverse events 
(AEs), and early clinical changes were compared within and between groups. Travel distances 
were estimated using zip codes.
Results: Mean attendance was 11.0 sessions in the hub and 10.5 sessions in the spoke (P=0.65). 
There was a single (mild) AE (hypoglycemia) in all three hub programs and no AEs in the 
three spoke programs. Mean COPD Assessment Test scores improved from 25.3 to 21.5 in the 
hub (P0.001, 95% CI 2.43–5.17) and from 23.4 to 18.8 (P0.001, 2.23–7.02) in the spoke 
group, with no difference between the groups (P=0.51, −3.35–1.70). Mean incremental shuttle 
walk test scores improved from 142 to 208 m (P0.001, 75–199) in the hub and from 179 
to 316 minutes in the spoke (P0.001, 39.3–92.4), with a greater improvement in the spoke 
(P=0.025, 9.31–133). Twenty-one patients saved a total of 8,609.8 miles over the three programs 
by having the PR in their local spoke, rather than traveling to the usual nearest (hospital) hub.
Conclusion: Video-conferencing, which links a local site to a standard PR program is feasible, 
safe, and demonstrates at least equivalent short-term clinical gains. Throughput can be increased, 
with less staffing ratios and significantly less traveling.
Keywords: video-linking, pulmonary rehabilitation, telemedicine, prudent healthcare
Introduction
Pulmonary rehabilitation (PR) is a multidisciplinary program designed to support people 
with chronic respiratory impairment.1 Although there is heterogeneity between programs, 
most incorporate exercise, education, and self-management support.1 Research consis-
tently demonstrates that PR improves symptoms, quality of life, and exercise capacity.2–5 
PR has also been shown to reduce admission and readmission rates and length of admis-
sion, particularly for patients with COPD.6–8 PR is now recommended as an integral 
part of care for people with COPD who remain limited by their chest despite optimal 
pharmacotherapy,9–11 and PR is now also advocated for people with bronchiectasis, inter-
stitial lung disease, and pre- and post-thoracic surgery, despite a smaller evidence base.11
Despite government recommendations that PR should be available for all those 
eligible,12 only 34.5% of eligible patients in Wales (UK) were offered PR in 2014.13 
Our group of hospitals in Hywel Dda University Health Board covers a semi-rural 
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population of 400,000 people living across a large geographi-
cal area (69.2 per square km population density). Barriers to 
travel as well as staff recruitment and retention meant only 
31% of our eligible population received PR13 with wide varia-
tions in delivery and one county not offering any. National 
policies recommend more adequate and long-term funding 
and the strategic use of technology to assist the delivery of 
PR in rural communities,14 particularly as journey time and 
distance have been shown to independently reduce PR enroll-
ment and completion.15 Research investigating the use of 
technology in healthcare most commonly use telemonitoring 
as opposed to other mediums.16,17 Although such interventions 
have been linked with positive outcomes,18 this has created 
a gap in the literature investigating asynchronous methods.
To address many of these issues, our PR team imple-
mented a hub and spoke model utilizing video-conferencing 
(VC) technology to simultaneously connect sites. We wanted 
to increase the number of people receiving PR but at little 
extra staff cost; we also wanted to standardize care and 
deliver it to those in need and closer to home, thus addressing 
at least three prudent healthcare principles.19
Methods
The aim of the present study was to evaluate the uptake, 
safety, technical feasibility, and effectiveness of delivering 
a VIrtual PulmonAry Rehabilitation (VIPAR) program. This 
is a service evaluation utilizing non-inferiority methodology, 
comparing people attending a hub site to those attending a 
spoke site.
Participants
As this was a service evaluation, the authors did not seek 
research ethical approval. All participants attending either 
the hub or spoke site between September 2017 and April 
2018 were included. The majority of participants had pre-
dominately COPD (GOLD 2019)10 with a minority having 
predominately other chronic lung conditions (Table 1). All 
participants had moderate to severe COPD, with Medical 
Research Council (MRC) breathlessness score 3, on opti-
mal medications, no exacerbations within 6 weeks, and had 
varying degrees of airflow obstruction. Individual up-to-date 
spirometry and comorbidity indexing was not performed at 
the time of this service evaluation but all participants were 
screened by appropriate clinicians previously and fulfilled 
the British Thoracic Society guidelines for suitability and 
safety to undergo PR.11 All were referred by their general 
practitioner (GP) or respiratory specialist. All participants 
attended the hub (hospital) for pre-assessment 1–2 weeks 
before commencing PR; they were offered PR in the closest 
centre (hub or spoke) and all chose their nearest location. 
Table 1 describes the groups at baseline.
hub site
The program was located in our hospital cardiopulmonary 
center. It consisted of twice weekly sessions for 7 weeks 
and incorporated both educational and exercise components 
according to best practice and current guidelines.6,11 We 
have reported twice weekly sessions over 7 weeks to have 
equivalent outcomes as three times weekly over 6 weeks.20 
Approximately, 7–10 participants attended the hub site 
for each 7-week program. The course was delivered by an 
experienced occupational therapist (OT), physiotherapist, 
and assistant exercise instructor. A supervised, personalized 
aerobic exercise session of 1–1.5 hours was followed by a 
20–40-minute talk delivered by the OT, respiratory nurse, 
dietician, or respiratory physicians. The OT also offered 
1:1 sessions and additional advice on anxiety management, 
breathlessness control, and breathing exercises for those 
who wanted.
spoke site
The program was conducted in a rural village hall (two 
cohorts) and community independent living center (one 
cohort). The hub and spoke sites were linked with the 
Polycom Real Presence Group 500 Video Conferencing Sys-
tem and Samsung DM65E-BR interactive screens, installed by 
Comcen. Around 6–8 participants attended the spoke site for 
the same (simultaneous) 7-week program. A physiotherapy 
technician (with agreed competencies) helped deliver the 
Table 1 Descriptive and inferential statistics for patients at baseline
Measures Hub 
(n=24)
Spoke 
(n=21)
P-value
age (years) 68.6 (12.8) 70.1 (10.8) P=0.67 (−8.93–5.79)
Female 58.3% 33.3% P=0.09 (0.25)
Diagnosis P=0.45 (0.14)
COPD n=19 n=16
Bronchiectasis n=2 n=1
Pulmonary fibrosis n=0 n=2
Chronic asthma n=2 n=1
Other n=1 n=1
CaT 25.2 (6.6) 24.0 (6.2) P=0.52 (−2.44–4.77)
MrC 3.5 (0.9) 3.3 (0.8) P=0.84
haDs-Depression 6.5 (2.7) 7.05 (2.6) P=0.47 (−2.21–1.03)
haDs-anxiety 8.2 (3.5) 7.60 (4.2) P=0.60 (−1.73–2.95)
IsWT (meters) 149 (80) 159 (133) P=0.77 (−78.1–58.1)
Notes: Data are given as mean and sD (in parenthesis) unless otherwise stated. 
P-values are given with associated confidence intervals. The correlation coefficient 
is provided for chi-squared tests.
Abbreviations: CaT, COPD assessment Test; MrC, Medical research Council 
breathlessness score; haDs, hospital anxiety and Depression score; IsWT, 
incremental shuttle walk test.
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personalized exercise component, under the direct observa-
tion of the staff at the hub site through VC. A respiratory 
nurse helped monitor participants’ safety and prepare gym 
equipment and VC facilities. The educational components 
were primarily delivered via VC from the hub in real time. 
Hub staff were available to travel to the spoke site on their 
own discretion if they thought more support was needed for 
a couple of sessions if more complex patients (eg, a lady with 
resting chronic hypoxia and receiving home ventilation) were 
attending. This was undertaken by staff on six occasions.
Data collection
The number of refusers and completers were recorded; any 
adverse event (AE) was reported by the team and discussed 
with the clinical lead who categorized it as mild, moderate, or 
severe, in line with International Conference on Harmonisa-
tion Good Clinical Practice guidelines.21
Technical issues with the VC (sound, image, connection, 
etc) were reported and dealt with as they arose.
Participants completed Hospital Anxiety and Depression 
Score (HADS), MRC dyspnea score, COPD Assessment Test 
(CAT), and incremental shuttle walk test (ISWT) 1–2 weeks 
before and on the final session of the PR program.
The amount of travel distance and time saved for the 
spoke patients attending their local spoke site compared 
to traveling to the hub site was calculated using zip codes.
statistical analysis
We used SPSS version 24. Categorical variables were com-
pared with chi-squared test. Between group changes were 
compared using independent t-tests and Wilcoxon rank-sum 
tests. Within group changes were measured with repeated 
mixed ANOVA applying Greenhouse–Geisser correction 
where the tests for sphericity were violated. Throughout the 
analysis, alpha error was chosen as 0.05.
Results
safety
There was one AE of hypoglycemia in a patient with diabe-
tes in the hub. It was treated with a sugary drink and biscuit 
with complete resolution and classified as mild. There were 
no reported AEs in the three spoke cohorts. One patient 
enrolled at the spoke site attended only two sessions and 
was admitted to the hospital for 6 weeks where she died of 
a hospital-acquired pneumonia. This was not deemed to be 
related to the VIPAR project.
Feasibility
About 61.9% of patients attended 12 or more sessions in the 
spoke sites, and 54.6% attended 12 or more sessions in the 
hub site. The mean (SD) attendance was 10.5 (4.21) at spoke 
site and 11.0 (2.63) at hub site (P=0.65, 95% CI −1.54–2.5).
The VC connection was lost in two out of 452 sessions, 
and sites were reconnected by redialling (the spoke partici-
pants continued exercising during these few minutes). Some 
participants had difficulty hearing a presentation in an early 
session which was resolved by microphone replacement and 
the closing of curtains to reduce echo.
effectiveness
Figures 1–4 display box and whisker plots showing the 
change from baseline for both groups for the CAT, ISWT, 
HADS-Depression (HADS-D), and HADS-Anxiety 
(HADS-A), respectively. There were significant improve-
ments from baseline in both groups for all four variables 
(P0.003 throughout).
MRC dyspnoea score also improved for both groups (plot 
not shown), with a mean change of −0.48 (SD=0.60) for the hub 
and −0.75 (SD=0.86) for the spoke; these changes were both 
statistically significant (P0.002 and P0.003, respectively). 
Analysis showed there were no significant differences between 
groups for MRC dyspnoea score (P=0.26, 95% CI −0.76−0.24). 
Both groups also showed similar improvements in CAT 
(P=0.51, 95% CI −3.35−1.70), HADS-D (P=0.07, 95% 
CI −2.93−0.13), and HADS-A (P=0.18, 95% CI −1.29−1.06).
The spoke site showed a greater improvement in ISWT 
(+137 m) compared to the hub site (+66 m; P=0.025, 95% 
CI 9.31–133).
Travel
The amount of travel distance saved was calculated by deter-
mining the difference in miles from the patients’ home to 
the hub site and subtracting the distance from their home to 
spoke site in those attending the spokes. We multiplied this 
by the number of sessions that patient attended. The total 
Figure 1 Box and whisker plot showing change in CaT scores for both groups.
Abbreviation: CaT, COPD assessment Test.
 &$7± +XE&KDQJH
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travel distance saved over the three cohorts was 8,610 miles 
at around 410 miles per patient.
Similarly, we compared journey time as estimated by 
Google Maps. The total travel time saved over the three 
cohorts was 14,750 minutes averaging 702 minutes or 
11.5 hours journey time per spoke patient.
Discussion
Our VIPAR model is a real-world pragmatic cohort study. 
Linking a spoke site to a pre-existing program is feasible 
with good uptake and completion; it appears safe and at least 
is equally effective in short-term gains in quality of life and 
walking distance than a standard PR service. Per participant, 
the staffing ratios and therefore overall costs are less.
Throughout, we developed VIPAR along four prudent 
healthcare principles.19 We developed it using patients’ and 
professionals’ opinions through coproduction; we wanted 
the most effective use of skills and often limited resources 
(staff and hospital space); we did “what is needed, no more, 
no less”; we were very keen to reduce inappropriate local 
variation where large rural areas have no access to PR.14 We 
involved staff in the development and implementation of 
technology alongside technology providers within healthcare, 
and kept the technology as simple as possible to minimize 
technical issues.22
The uptake of both sites was similar and compare well 
with the 50%–90% uptake values found in the literature; 
however, a large heterogeneity in uptake rates has been 
reported.23 Interviews with staff and patients and thematic 
analysis (not reported here) confirms its popularity. The 
mean attendance rate of 75% of sessions for the spoke site 
compares very well to standard PR.24–27 This suggests that 
participants are more willing to attend local groups and nei-
ther the spoke nor hub was deterred by VC equipment with 
no loss of quality of the program on either site through using 
monitors and remote speakers.
There were no major technical problems embedding and 
using the VC systems by staff who had minimum training 
and had never used it to deliver PR. The VC technology also 
worked in a very rural setting where there is limited Internet 
service. Our standard clinical (UK-NHS) information tech-
nology frameworks allowed National Health Service (NHS) 
firewalls. Technical issues, such as loss of connectivity, 
were quickly dealt with and did not require NHS IT Services 
support. There were no AEs in the spoke site despite lower 
staffing ratios, and only one minor AE, not related to the VC, 
was reported during the entire project.
Both groups showed clinically relevant and statistically 
significant improvements in disease-specific quality of life 
questionnaires (CAT),27 and the spoke group achieved similar 
results within functional exercise (ISWT).28 The hub group, 
although statistically significant, narrowly missed the mini-
mum clinical difference of improvement in ISWT.28 There 
were similar improvements in generic questionnaires, depres-
sion (HADS-D), anxiety (HADS-A), and breathlessness 
Figure 2 Box and whisker plot showing change in IsWT scores for both groups.
Abbreviation: IsWT, incremental shuttle walk test.
 ,6:7± +XE&KDQJHLQ,6:
7PHWHUV
6SRNH
Figure 3 Box and whisker plot showing change in haDs-D scores for both groups.
Abbreviation: haDs-D, hospital anxiety and Depression score-Depression.
 +$'6'±±± +XE&KDQJHLQ
+$'6'
6SRNH
Figure 4 Box and whisker plot showing change in haDs-a scores for both groups.
Abbreviation: haDs-a, hospital anxiety and Depression score-anxiety.
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scores (MRC) but the clinical importance of a change of 
2 (HADS), when the mean baseline scores were in the normal 
range, remains debatable. Our overall group improvements 
are similar to traditional models of PR.2–5 Although both 
groups had comparable gains in symptom burden and quality 
of life, participants in the spoke site showed a significantly 
bigger increase in ISWT from baseline. The small numbers 
were influenced by two participants showing exceptional 
improvements. The hub site did have a lower mean ISWT 
at baseline which, although not statistically significant, may 
suggest a more disabled cohort and some selection bias 
toward fitter people being referred by the GPs to the spoke 
site. However, as we gain experience, we are rotating more 
experienced staff to the spoke site if needed, at least for the 
first two sessions, and so VIPAR is flexible for every cohort.
The VIPAR project saved a total of 8,610 miles of travel-
ing for spoke patients by enabling them to attend a site closer 
to their homes. This is equivalent to driving to the US and 
back. Also, 4,750 minutes of traveling was saved, which is 
equivalent to 10.24 days. This represents a significant eco-
logical impact benefit but is likely to improve outcomes as 
distance and travel time are independent predictors of poor 
PR attendance.15
The latest Cochrane review of PR concludes:
It is our opinion that additional RCTs comparing pulmonary 
rehabilitation and conventional care in COPD are not war-
ranted. Future research studies should focus on identifying 
which components of pulmonary rehabilitation are essential, 
its ideal length and location, the degree of supervision 
and intensity of training required and how long treatment 
effects persist.3
Although previous research has shown that PR can be 
effectively delivered within a home setting,29,30 this removes 
both the supervised exercise and social interaction for 
patients, where social isolation has been linked to poor health 
outcomes.31 VIPAR fills some of the gaps in the knowledge 
on community-based PR and offers a degree of supervision, 
while also suggesting how simple technology can reduce 
distance and travel time and improve access.
Stickland et al used VC equipment to link a hub and spoke 
site to deliver PR for people with COPD.32 Exercise and edu-
cational components were largely similar to those described 
above; however, their program was held twice weekly for 
8 weeks, where 8–12 and 2–6 patients were typically enrolled 
at the hub and spoke sites, respectively. Their staffing was 
higher with respiratory therapists and other higher qualified 
health professionals present at “both” hub and spoke sites, 
although the exact number was not specified. They found 
similar gains, where quality of life and functional exercise 
significantly increased between baseline and follow-up, with 
no differences between groups. Attendance at both hub (79%) 
and spoke (75%) sites were the same as ours. They did not 
report any safety or connectivity data and did not include a 
measure of anxiety or depression nor travel distance and time.
Conclusion
Future work would be to add a second spoke site to the hub 
and measure feasibility, safety, and throughput. We are 
also measuring health contacts and admissions in the year 
following VIPAR. It can also be used to “top-up” PR or test 
stroke, cardiac, and cancer rehabilitation models, especially 
where a shortage of staff and rurality preclude local deliv-
ery. Any model should use mobile VC and rotate hub and 
spoke sites to address local needs and greatest needs first 
(eg, longest waiting lists).
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